LLY
Why the Market Dipped But Eli Lilly (LLY) Gained Today
In the latest trading session, Eli Lilly (LLY) closed at $773.29, marking a +1.07% move from the previous day.
Read moreDetails
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware...
Read moreDetails
5 Large Drug Stocks to Keep An Eye On in the New Year
R&D innovation is likely to remain a major focus area in 2025. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY),...
Read moreDetails
Why Eli Lilly (LLY) Dipped More Than Broader Market Today
Eli Lilly (LLY) reachead $773.84 at the closing of the latest trading day, reflecting a -1.19% change compared to its...
Read moreDetails
Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?
Stocks splits have been a huge market theme in 2024, with big names across industries, from technology giant Nvidia to...
Read moreDetails
Billionaire Philippe Laffont Is Selling Artificial Intelligence Champion Nvidia and Piling Into These Two Industry Leaders
If you're looking for top stocks, there's no need to reinvent the wheel. The Securities and Exchange Commission makes it...
Read moreDetails
2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades
If you're too busy to keep monitoring your stock portfolio every other day, then investing in stocks that won't cause...
Read moreDetails
Better Buy: Eli Lilly vs. Novo Nordisk.
It seems like just yesterday that vaccines used to combat the COVID-19 pandemic were all anyone in the medical world...
Read moreDetails
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
Read moreDetails